Mohamad A. Hussein, MD | Authors

Research on Thalidomide in Solid Tumors, Hematologic Malignancies, and Supportive Care

November 01, 2000

Interest in thalidomide (Thalomid) has intensified in recent years as research has identified and elucidated its immunomodulatory, anti-inflammatory, and antiangiogenic properties. In this supplement, we present a selection of abstracts